CNBX Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CNBX Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q2 2024.
  • CNBX Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 14, 2024 was 31.1M shares, a 82.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 31.1M +14.1M +82.6% Jul 14, 2024 10-Q 2024-07-15
Q1 2024 31.1M +26.1M +526% Apr 12, 2024 10-Q 2024-04-16
Q4 2023 31.1M +29.9M +2373% Jan 12, 2024 10-Q 2024-01-12
Q2 2023 17M +15.8M +1254% Jul 14, 2023 10-Q 2023-07-14
Q1 2023 4.97M -144M -96.7% Apr 12, 2023 10-Q 2023-04-14
Q4 2022 1.26M -147M -99.2% Jan 14, 2023 10-Q 2023-01-13
Q2 2022 1.26M -145M -99.1% Jul 14, 2022 10-Q 2022-07-14
Q1 2022 149M +10.3M +7.39% Apr 12, 2022 10-Q 2022-04-12
Q4 2021 149M +13.4M +9.93% Jan 14, 2022 10-Q 2022-01-13
Q2 2021 147M +11.6M +8.57% Jul 14, 2021 10-Q 2021-07-14
Q1 2021 139M +4.12M +3.05% Apr 12, 2021 10-Q 2021-04-14
Q4 2020 135M +739K +0.55% Jan 14, 2021 10-Q 2021-01-14
Q3 2020 135M Nov 4, 2020 10-K 2020-11-04
Q2 2020 135M +622K +0.46% Jul 14, 2020 10-Q 2020-07-14
Q1 2020 135M +577K +0.43% Apr 12, 2020 10-Q 2020-04-13
Q4 2019 134M +80K +0.06% Nov 29, 2019 10-K 2019-11-29
Q2 2019 134M +13.4M +11.1% Jul 14, 2019 10-Q 2019-07-15
Q1 2019 134M +14M +11.6% Apr 12, 2019 10-Q 2019-04-15
Q4 2018 134M +14.9M +12.4% Jan 14, 2019 10-Q 2020-01-14
Q2 2018 121M +2.75M +2.32% Jul 13, 2018 10-Q 2018-07-16
Q1 2018 120M +5.33M +4.63% Apr 4, 2018 10-Q 2018-04-05
Q4 2017 120M +5.44M +4.77% Jan 14, 2018 10-Q 2018-01-16
Q2 2017 118M +12.5M +11.9% Jul 14, 2017 10-Q 2017-07-17
Q1 2017 115M +9.37M +8.86% Apr 18, 2017 10-Q 2017-04-14
Q4 2016 114M +12M +11.7% Jan 17, 2017 10-Q 2017-01-17
Q2 2016 106M +4.87M +4.83% Jul 12, 2016 10-Q 2016-07-13
Q1 2016 106M +5.06M +5.03% Apr 8, 2016 10-Q 2016-04-18
Q4 2015 102M +1.52M +1.51% Dec 31, 2015 10-K 2016-01-07
Q2 2015 101M +19.2M +23.4% Jul 15, 2015 10-Q/A 2015-11-17
Q1 2015 101M +79.8M +382% Apr 17, 2015 10-Q/A 2015-11-17
Q4 2014 101M +80M +387% Jan 12, 2015 10-Q/A 2015-11-17
Q2 2014 81.8M +81.1M +11920% Jul 9, 2014 10-Q/A 2014-07-15
Q1 2014 20.9M +20.2M +2970% Mar 15, 2014 10-Q 2014-04-01
Q4 2013 20.7M +20M +2940% Jan 13, 2014 10-Q 2014-01-14
Q2 2013 680K 0 0% Jul 4, 2013 10-Q 2013-07-15
Q1 2013 680K 0 0% Apr 12, 2013 10-Q 2013-04-15
Q4 2012 680K 0 0% Jan 11, 2013 10-Q 2013-01-14
Q2 2012 680K Jul 5, 2012 10-Q 2012-07-06
Q1 2012 680K Apr 10, 2012 10-Q 2012-04-13
Q4 2011 680K Jan 14, 2012 10-Q 2012-01-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.